abstract |
The present invention provides compositions and methods for treating or preventing pulmonary infections, particularly pulmonary infections caused by antibiotic-resistant strains of bacteria and/or pulmonary infections in patients at high risk of developing such infections, including patients suffering from chronic obstructive pulmonary disease, bronchiectasis and/or cystic fibrosis. |